Zobrazeno 1 - 10
of 101
pro vyhledávání: '"Dieter, Hörsch"'
Autor:
Sebastian Krug, Thomas Kegel, Thomas M. Gress, Anja Rinke, Leonidas Apostolidis, Henning Jann, Alexander König, Dieter Hörsch, Jörg Schrader, Thomas J. Ettrich, Michael Richter, Jörg Steighardt, Patrick Michl
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-9 (2021)
Abstract Background Cytotoxic chemotherapy combinations and targeted agents represent established treatment concepts in advanced pancreatic neuroendocrine tumors (PNETs). However, response rates, side effects and outcome data strongly vary among thes
Externí odkaz:
https://doaj.org/article/19ea4eac44d448f1a68eca27024409f7
Autor:
Frank Oliver Henes, Dieter Hörsch, Antonin Kayser, Ulrich-Frank Pape, Anja Rinke, Ansgar W. Lohse, Jörg Schrader, Dominik Reher, Uli Fehrenbach, Birgit Cremer, Jakob R. Izbicki
Publikováno v:
Neuroendocrinology. 112:595-605
Introduction: Incidence of pancreatic neuroendocrine tumours (pNETs) is on the rise. The only curative treatment is surgical resection in localized or oligo-metastatic disease. However, patients may present with locally advanced or unresectable prima
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e1892508ee0917f7d66e30994585aa6
https://doi.org/10.1159/000518895
https://doi.org/10.1159/000518895
Autor:
Dominik Reher, Thomas M. Gress, Anja Rinke, Jörg Schrader, Daniel Kaemmerer, Richard P. Baum, Dieter Hörsch, Robert Fijalkowski
Publikováno v:
Neuroendocrinology. 112:547-554
Introduction: Carcinoid syndrome is the most frequent functional syndrome of neuroendocrine neoplasia. It is characterized by flushing, diarrhea, wheezing, hypotension, and exanthema and may cause carcinoid heart disease. Methods: We assessed clinica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd145c33e95c8052b82291fcd257f371
https://doi.org/10.1159/000518651
https://doi.org/10.1159/000518651
Autor:
Rocio Garcia-Carbonero, Piero Ferolla, Marianne Pavel, Nicola Fazio, Martyn Caplin, C. Lombard-Bohas, Eric Lim, Andrea Frilling, J.-Y. Scoazec, Eric Baudin, Ulrich Knigge, P.L. Filosso, Alfredo Berruti, Dieter Hörsch, W. W. de Herder, Anders Sundin, Catharina M. Korse
Publikováno v:
Annals of Oncology, 32(4), 439-451. Elsevier Ltd.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06ba45042b9eb6e27e14546f5aebdf77
https://pure.eur.nl/en/publications/83564c94-4175-4310-b591-0b8741d65d4a
https://pure.eur.nl/en/publications/83564c94-4175-4310-b591-0b8741d65d4a
Autor:
Alfredo Berruti, W. W. de Herder, Eric Baudin, Rocio Garcia-Carbonero, Catharina M. Korse, Anders Sundin, A. Frilling, C. Lombard-Bohas, Marianne Pavel, Piero Ferolla, Dieter Hörsch, Nicola Fazio, Ulrich Knigge, P.L. Filosso, Martyn Caplin, J.-Y. Scoazec, Eric Lim
Publikováno v:
Annals of Oncology. 32:1453-1455
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a69175531d30d61c7a6a5194be900cad
https://doi.org/10.1016/j.annonc.2021.08.2150
https://doi.org/10.1016/j.annonc.2021.08.2150
Autor:
Pamela L. Kunz, Lowell Anthony, Marianne Pavel, Phillip Banks, Pablo Lapuerta, Matthew H. Kulke, Staffan Welin, Richard R.P. Warner, Chad McKee, Joseph S. Dillon, Thomas M. O'Dorisio, Emily K. Bergsland, Dieter Hörsch
Publikováno v:
J Gastrointest Cancer
Background Telotristat ethyl is approved to treat carcinoid syndrome diarrhea in combination with somatostatin analogs. In TELESTAR and TELECAST phase III studies, patients with carcinoid syndrome received telotristat ethyl 250 or 500 mg 3 times per
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3a2c25273888374bad589bca85750be
https://doi.org/10.1007/s12029-020-00375-2
https://doi.org/10.1007/s12029-020-00375-2
Autor:
null Marie‐Louise F. van Velthuysen, null Anne Couvelard, null Guido Rindi, null Nicola Fazio, null Dieter Hörsch, null Els J. Nieveen van Dijkum, null Günter Klöppel, null Aurel Perren
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5696a7238c3bc5120dc1741424c2a571
https://doi.org/10.1111/jne.13100/v2/response1
https://doi.org/10.1111/jne.13100/v2/response1
Autor:
Staffan Welin, David J. Gross, Lowell Anthony, Phillip Banks, Kenneth Kassler-Taub, Polina Binder, Juan W. Valle, Matthew H. Kulke, Martyn Caplin, Marianne Pavel, Marta Benavent, Emily K. Bergsland, Dieter Hörsch, Kjell Öberg, Pablo Lapuerta
Publikováno v:
Neuroendocrinology
[Introduction] Telotristat ethyl is indicated for use in combination with somatostatin analogs (SSAs) to treat carcinoid syndrome (CS) diarrhea uncontrolled by SSAs alone in adults, but long-term safety and efficacy data beyond 48 weeks are needed.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb676ada73bc2c84b816431744a94231
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-502260
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-502260
Autor:
Sebastian Maasberg, Ulrich-Frank Pape, Christian Fottner, Peter E. Goretzki, Martin Anlauf, Dieter Hörsch, Birgit Cremer, Dominik M. Schulte, Detlef Quietzsch, Frank Scheerer, Gabriele Pöpperl, Thorsten D. Poeppel, Nehara Begum, Christian Grohé, Anja Rinke, Ursula Plöckinger, Betram Wiedenmann, Rudolf Arnold, Peter Neuhaus, Wolfram H. Knapp, Hendrick Lehnert, Christoph Auernhammer, Marianne Pavel, Ludwig Fischer von Weikersthal, Bernd Schmidt, Harald H. Klein, Markus Essler, Jörg-Dietrich Neumann, Susanne Hamann, Frank Steffens, Frank Demtröder, Anke Kröcher, Flavius Zoicas, Harald Lahner, Frank Weber, Michael Geißler, Andreas Raffel, Markus Krausch, Patrick Zimmermann, Markus M. Lerch, Thomas Wirth, Matthias Lang, Samer Ezziddin, Frank Lammert, Marina Bischoff, Annelore Altendorf-Hofmann, Lothar Müller, Albrecht Hoffmeister, Silke Klose, Thomas J. Musholt, Stefan Post, Ralf Gertler, Hubert Scheuerlein, Tanja Bergmann, Guido Bisping, Andreas Knauerhase, Bernhard Rendenbach, Volker Groß, Michael Scheurlen, Heiner Mönig, Theodor Kudlich, Patricia Grabowski, Felix Watza, Klemens Scheidhauer, Elke Möbius
Publikováno v:
Onkologische Welt. 10:182-192
ZusammenfassungNeuroendokrine Neoplasien (NEN) umfassen eine seltene Tumorentität mit heterogener Biologie, Prognose und therapeutischen Optionen. In Zusammenhang mit der kürzlichen Publikation der ersten deutschen Leitlinie zur Diagnostik und Ther
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::82ffa72b7db575bd9403cee6cc9352eb
https://doi.org/10.1055/a-0864-8520
https://doi.org/10.1055/a-0864-8520
Autor:
Dieter Hörsch, Merten Hommann, Daniel Kaemmerer, Susanne Sehner, Matthias Twrznik, Harshad R. Kulkarni, Richard P. Baum
Publikováno v:
Annals of Surgery. 274:e45-e53
OBJECTIVE The aim of the study was to compare impact on survival after resection of primary tumors (PTs) after peptide receptor radionuclide therapy (PRRT). BACKGROUND PRRT is a highly effective therapeutic option to treat locally advanced or metasta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc0e13941ce9fdf5ac5a4808c9f50c38
https://doi.org/10.1097/sla.0000000000003237
https://doi.org/10.1097/sla.0000000000003237